Bristol Myers Squibb says Alzheimer’s is the biggest market for new schizophrenia drug
In this article BMY Follow your favorite stocksCREATE FREE ACCOUNTThe Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, onContinue Reading